Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Recent Advances in Hematology - 5 - Vandana Puri,  Jasmita, Brig Tathagata Chatterjee

Recent Advances in Hematology - 5

Buch | Softcover
592 Seiten
2024
Jaypee Brothers Medical Publishers (Verlag)
978-93-6616-832-6 (ISBN)
CHF 78,55 inkl. MwSt
  • Titel nicht im Sortiment
  • Artikel merken

Vandana Puri MD (Pathology) DNB (Pathology) DM (Hematopathology) MNAMS Jasmita Dass MD (Pathology) DM (Hematopathology) Brig Tathagata Chatterjee MD (Pathology) PGD (Oncopathology) DM (Hematopathology) FIAMS FUICC 

1. Molecular Diagnosis of Inherited Hemolytic Anemias Beyond Thalassemia

2. Recent Advances in the Prognostication of Chronic Lymphocytic Leukemia and Multiple Myeloma

3. WHO 2022 Update of the Classification of MDS and MPN: Practical Algorithms for Diagnosis

4. Critical Appraisal of WHO and ICC Classification of Acute Myeloid Leukemia

5. CAR-T Therapy: Managing Toxicity and Long-term Outcome Assessment

6. Noninvasive Prenatal Diagnosis for Sickle Cell Anemia and Thalassemia

7. Molecular Landscape of Diffuse Large B-cell Lymphoma

8. B-ALL Management in the Era of Immunotherapy

9. Diagnosis of Ph-like B-ALL: The Ideal Approach in the Indian Setting

10. Point-of-Care Testing in Coagulation

11. MicroRNAs in Hematology

12. How to Assess Measurable Residual Disease in Acute Myeloid Leukemia

13. Relevance of Screening of Myeloid/Lymphoid Neoplasms for Germline Predisposition

14. Recent Advances in the Diagnosis and Treatment of Hodgkin Lymphoma

15. Updates in the Diagnosis of the Antiphospholipid Syndrome

16. Heparin-induced Thrombocytopenia and Vaccine-induced Thrombocytopenia

17. Direct Oral Anticoagulants: When to Prescribe and How to Monitor?

18. How to Approach a Case of Microcytic Hypochromic Anemia Not Responding to Iron Therapy

19. Measurable Residual Disease in B-cell Acute Lymphoblastic Leukemia: What is Known and What is New?

20. Revisiting B-ALL MRD in CAR-T Cell and Blinatumomab Era

21. Measurable Residual Disease in T-cell Acute Lymphoblastic Leukemia/Lymphoma

22. Setting Up a Diagnostic Laboratory: Costing and Inventory Management

23. How to Set Up a Molecular Hematology Laboratory?

24. Optical Genome Mapping: Introduction of New Era of Cytogenomics in Hematological Malignancies

25. Hemoglobin Fraction Analysis in the Diagnosis of Hemoglobinopathies - Methods, Advantages, Pitfalls and Updates

26. Approach to Monocytosis

27. Juvenile Myelomonocytic Leukemia - Recent Updates

28. Case-based Approach to Eosinophilia

29. Monitoring and Follow-up of Chronic Myeloid Leukemia Including Tyrosine Kinase Domain Mutation Assessment

30. Primary Immunodeficiency Disorders: Approach to Diagnosis and Treatment

31. New Updates in Histiocytic Disorders: Where do We Stand in 2024?

32. Role of Genomic Techniques in the Management of Acute Leukemia

33. Thrombophilia Workup: When, Whom, and What to Test?

34. Amyloidosis: Newer Insights in Diagnosis

35. Minimal/Measurable Residual Disease in Myeloma

36. Quality Control in Hematology Cell Counters and Coagulation Laboratory: Good Laboratory Practices

37. Immunohematology in Solving Cases of Autoimmune Hemolytic Anemia

38. Recent Advances in Splenic Lymphomas: Histopathology and Flow Cytometry

39. Genetics in Hemophilia and Platelet Function Disorders

40. Neonatal Transfusion - Newer Parameters in Cell Counters

Erscheinungsdatum
Verlagsort New Delhi
Sprache englisch
Maße 160 x 242 mm
Gewicht 872 g
Themenwelt Medizinische Fachgebiete Innere Medizin Hämatologie
ISBN-10 93-6616-832-9 / 9366168329
ISBN-13 978-93-6616-832-6 / 9789366168326
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Wie Leukämien und Lymphome bei Kindern heilbar wurden

von Christian Müller

Buch | Softcover (2025)
Lehmanns Media (Verlag)
CHF 41,90